Ovral-28 Interactions
There are 500 drugs known to interact with Ovral-28 (ethinyl estradiol / norgestrel), along with 23 disease interactions, and 9 alcohol/food interactions. Of the total drug interactions, 78 are major, 373 are moderate, and 49 are minor.
- View all 500 medications that may interact with Ovral-28
- View Ovral-28 alcohol/food interactions (9)
- View Ovral-28 disease interactions (23)
Most frequently checked interactions
View interaction reports for Ovral-28 (ethinyl estradiol / norgestrel) and the medicines listed below.
- adalimumab
- Adderall (amphetamine / dextroamphetamine)
- Ambien (zolpidem)
- aspirin
- betamethasone
- Chlorpheniramine (Allergy) (chlorpheniramine)
- cholecalciferol
- clonazepam
- codeine
- cortisone
- duloxetine
- Gonak Hypromellose (hydroxypropyl methylcellulose ophthalmic)
- ibuprofen
- ibuprofen / salicylic acid topical
- Iron Sulfate (ferrous sulfate)
- lansoprazole
- levothyroxine
- Lexapro (escitalopram)
- Lortab (acetaminophen / hydrocodone)
- methadone
- methylphenidate
- Migraine Formula (acetaminophen / aspirin / caffeine)
- nifedipine
- Nuvigil (armodafinil)
- Paracetamol (acetaminophen)
- Paxlovid (nirmatrelvir / ritonavir)
- prochlorperazine
- propranolol
- quinine
- risedronate
Ovral-28 alcohol/food interactions
There are 9 alcohol/food interactions with Ovral-28 (ethinyl estradiol / norgestrel).
Ovral-28 disease interactions
There are 23 disease interactions with Ovral-28 (ethinyl estradiol / norgestrel) which include:
- smoking
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- breast malignancy
- liver disease
- thromboembolism
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
- hyperlipidemia
- weight gain
Report options
More about Ovral-28 (ethinyl estradiol / norgestrel)
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.